EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma

Huitao Wu, Junyan Zhang, Li Fu, Rilige Wu, Zhenyang Gu, Chengliang Yin iD, Kunlun He

Technology in Cancer Research & Treatment · 2023

DOI: 10.1177/15330338221147772 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology in Cancer Research & Treatment, 2023. Verfasst von Huitao Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Big Data Research Center, Medical Innovation Research Division of PLA General Hospital, Beijing, P. R. China. Hauptthemen laut MEDLINE: Ferroptosis, Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: 2020 China Industrial Technology Infrastructure Public Service Platform Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diffuse large B-cell lymphoma (DLBCL) is a well-differentiated disease, which makes the diagnosis and therapeutic strategy a difficult problem. While ferroptosis, as an iron-dependent form of regulated cell death, it plays an important role in causing several types of cancer. This study is aimed at exploring the prognostic value of ferroptosis-related genes in DLBCL.

Methods

In our study, mRNA expression and matching clinical data of DLBCL patients were derived from Gene Expression Omnibus (GEO) database. First, multivariate cox regression model and nomogram which can predict the DLBCL patients’ prognosis were built and validated. The multigene signature was constructed and optimized by the least absolute shrinkage and selection operator (LASSO) cox regression model. Also, ferroptosis-related subtypes were developed by consistent cluster. Last but not least, we explored the association between categories of infiltrating immune cells and model genes’ expression.

Results

Our results showed that 27 gene expressions were correlated with overall survival (OS) in the univariate cox regression analysis. A 4-gene signature was constructed through these genes to stratify patients into high-low risk groups using risk score derived from model (model 1:gene expression model). The OS of patients in the high-risk group was shorter than that of patients in the low-risk group in the TNM stage and clinically distinct subtypes (activated B cell [ABC], germinal center B cell [GCB]) ( P < .001). Furthermore, it was shown that the risk score was an independent factor in clinical cox regression model for OS (model 2:clinical model) (HR>1, P < .010). Besides, in consistent cluster analysis, ferroptosis prognosis status was different among 3 subtypes. Moreover, the correlation analysis between 4-gene with immune cells showed dendritic cells may be significantly associated with DLBCL.

Conclusion

This research constructed an innovative ferroptosis-related gene signature for prognostic estimation of DLBCL patients. Solutions targeting ferroptosis could be an important therapeutic intervention for DLBCL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisLymphoma, Large B-Cell, DiffuseHumansB-LymphocytesCluster AnalysisDatabases, FactualPrognosis

Stichwörter der Autor:innen

diffuse large B cell lymphomaferroptosisleast absolute shrinkage and selection operator coxprognosissignature

Autor:innen und Institutionen

  • Medical Big Data Research Center, Medical Innovation Research Division of PLA General Hospital, Beijing, P. R. China.
  • Intelligent Healthcare Team, Baidu Inc., Beijing, China.
  • National Engineering Laboratory for Medical Big Data Application Technology, 104607Chinese PLA General Hospital, Beijing, China.
  • Key Laboratory of Novel Materials for Sensor of Zhejiang Province, College of Materials and Environmental Engineering, 12626Hangzhou Dianzi University, Hangzhou, China.
  • The Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Medical Innovation Research Division of Chinese PLA General Hospital, Beijing, China.

ORCID-Profile: Chengliang Yin

Förderung

  • 2020 China Industrial Technology Infrastructure Public Service Platform Project

Zitieren

APA

Wu, H., Zhang, J., Fu, L., Wu, R., Gu, Z., Yin, C., & He, K. (2023). Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma. Technology in Cancer Research & Treatment. https://doi.org/10.1177/15330338221147772

Vancouver

Wu H, Zhang J, Fu L, Wu R, Gu Z, Yin C, et al. Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma. Technology in Cancer Research & Treatment. 2023. doi:10.1177/15330338221147772

BibTeX
@article{Wu2023,
  author = {Wu, Huitao and Zhang, Junyan and Fu, Li and Wu, Rilige and Gu, Zhenyang and Yin, Chengliang and He, Kunlun},
  title = {Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma},
  journal = {Technology in Cancer Research & Treatment},
  year = {2023},
  doi = {10.1177/15330338221147772}
}
Kostenlos starten →